Total Payments
$1.8M
2024 Payments
$261,072
Companies
59
Transactions
3,387
Medicare Patients
5,581
Medicare Billing
$802,528
Payment Breakdown by Category
Other$1.3M (70.4%)
Travel$372,798 (20.7%)
Consulting$100,339 (5.6%)
Food & Beverage$58,645 (3.3%)
Education$650.57 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.0M | 513 | 55.8% |
| Travel and Lodging | $372,798 | 820 | 20.7% |
| Honoraria | $263,206 | 109 | 14.6% |
| Consulting Fee | $100,339 | 43 | 5.6% |
| Food and Beverage | $58,645 | 1,878 | 3.3% |
| Education | $650.57 | 24 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $359,841 | 638 | $0 (2024) |
| Amgen Inc. | $303,250 | 496 | $0 (2024) |
| GENZYME CORPORATION | $225,971 | 284 | $0 (2024) |
| Horizon Therapeutics plc | $217,422 | 260 | $0 (2023) |
| UCB, Inc. | $127,942 | 274 | $0 (2024) |
| Horizon Pharma plc | $110,515 | 134 | $0 (2018) |
| Celgene Corporation | $92,983 | 142 | $0 (2019) |
| Mallinckrodt Enterprises LLC | $71,800 | 116 | $0 (2019) |
| GlaxoSmithKline, LLC. | $69,839 | 98 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $64,129 | 94 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $261,072 | 391 | ABBVIE INC. ($84,231) |
| 2023 | $190,437 | 387 | ABBVIE INC. ($53,388) |
| 2022 | $218,907 | 435 | Horizon Therapeutics plc ($46,565) |
| 2021 | $181,936 | 329 | Amgen Inc. ($41,126) |
| 2020 | $125,631 | 235 | Amgen Inc. ($46,159) |
| 2019 | $374,189 | 564 | Horizon Therapeutics plc ($91,974) |
| 2018 | $303,739 | 607 | Horizon Pharma plc ($100,387) |
| 2017 | $145,571 | 439 | AbbVie, Inc. ($46,385) |
All Payment Transactions
3,387 individual payment records from CMS Open Payments — Page 1 of 136
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $675.00 | General |
| Category: Bone Health | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: Immunology | ||||||
| 12/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $703.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $315.27 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $302.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $896.95 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $463.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | Cash or cash equivalent | $10.90 | General |
| Category: Bone Health | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Bone Health | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: Immunology | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Bone Health | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| 12/09/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | In-kind items and services | $1,679.60 | General |
| Category: Bone Health | ||||||
| 12/07/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,664.00 | General |
| Category: Rheumatology | ||||||
| 12/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $759.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $396.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $386.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $41.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $37.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | In-kind items and services | $60.00 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $115.58 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,272 | 6,311 | $469,123 | $190,820 |
| 2022 | 20 | 1,366 | 5,874 | $640,182 | $188,974 |
| 2021 | 20 | 1,455 | 7,935 | $568,356 | $214,391 |
| 2020 | 19 | 1,488 | 8,719 | $562,442 | $208,342 |
Total Patients
5,581
Total Services
28,839
Medicare Billing
$802,528
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 468 | 899 | $155,685 | $79,479 | 51.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 58 | 4,022 | $171,367 | $74,075 | 43.2% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2023 | 16 | 27 | $69,397 | $15,174 | 21.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 50 | 70 | $25,241 | $6,144 | 24.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 306 | 506 | $5,060 | $4,146 | 81.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $8,016 | $3,694 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 51 | $5,894 | $3,230 | 54.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 116 | 216 | $10,868 | $2,111 | 19.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 30 | 40 | $9,408 | $1,566 | 16.6% |
| 20605 | Aspiration and/or injection of fluid from medium joint | Office | 2023 | 12 | 12 | $2,273 | $455.38 | 20.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 26 | 27 | $789.80 | $230.36 | 29.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 34 | 40 | $623.00 | $223.92 | 35.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 43 | 254 | $3,363 | $217.32 | 6.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 37 | $334.80 | $40.40 | 12.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 26 | 80 | $803.30 | $34.63 | 4.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 430 | 987 | $165,816 | $81,374 | 49.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 63 | 3,276 | $237,600 | $52,543 | 22.1% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2022 | 23 | 47 | $135,924 | $28,619 | 21.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 61 | 94 | $30,510 | $7,873 | 25.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $18,180 | $4,341 | 23.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 144 | 305 | $14,945 | $2,850 | 19.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 21 | $5,733 | $2,442 | 42.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $4,902 | $2,395 | 48.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 318 | 578 | $5,780 | $1,686 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 24 | $2,664 | $1,487 | 55.8% |
About Dr. James Mossell, D.O
Dr. James Mossell, D.O is a Rheumatology healthcare provider based in Tifton, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720195837.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Mossell, D.O has received a total of $1.8M in payments from pharmaceutical and medical device companies, with $261,072 received in 2024. These payments were reported across 3,387 transactions from 59 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.0M).
As a Medicare-enrolled provider, Mossell has provided services to 5,581 Medicare beneficiaries, totaling 28,839 services with total Medicare billing of $802,528. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Tifton, GA
- Active Since 08/24/2006
- Last Updated 12/01/2020
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1720195837
Products in Payments
- KRYSTEXXA (Biological) $223,103
- Otezla (Drug) $174,541
- Enbrel (Biological) $150,798
- RINVOQ (Biological) $133,765
- KEVZARA (Drug) $128,130
- ACTHAR (Biological) $121,391
- KRYSTEXXA (Drug) $110,354
- Cimzia (Drug) $97,924
- KEVZARA (Biological) $77,346
- BENLYSTA (Biological) $69,839
- Humira (Biological) $61,721
- SKYRIZI (Biological) $56,796
- EVENITY (Biological) $38,331
- LUPKYNIS (Drug) $24,566
- Bimzelx (Biological) $23,900
- COSENTYX (Biological) $21,878
- XELJANZ (Drug) $20,547
- Rinvoq (Biological) $18,549
- OFEV (Drug) $16,090
- PURIFIED CORTROPHIN GEL (Drug) $11,559
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.